Wahlen b. Laufen, Switzerland

Thomas Josef Troxler

USPTO Granted Patents = 18 

 

 

Average Co-Inventor Count = 4.6

ph-index = 5

Forward Citations = 60(Granted Patents)


Location History:

  • Wahlen, CH (2003 - 2009)
  • Wahlen b. Laufen, DE (2010)
  • Wahlen b. Laufen, CH (2010 - 2023)

Company Filing History:


Years Active: 2003-2023

Loading Chart...
Loading Chart...
Loading Chart...
18 patents (USPTO):

Title: The Innovations of Thomas Josef Troxler

Introduction: Thomas Josef Troxler, an accomplished inventor based in Wahlen b. Laufen, Switzerland, has made significant contributions to the field of pharmaceuticals. With a remarkable portfolio of 18 patents, Troxler's work primarily focuses on the development of innovative compounds that have therapeutic applications.

Latest Patents: Among his latest inventions are various carboxamide derivatives. The present inventions provide a compound of formula (I) or a pharmaceutically acceptable salt thereof, alongside methods for manufacturing these compounds. Furthermore, these innovations offer a combination of pharmacologically active agents and pharmaceutical compositions, showcasing Troxler's dedication to advancing medical science.

Career Highlights: Troxler’s career has flourished in his role at Novartis AG, a leading global healthcare company. His extensive patent portfolio reflects his expertise and commitment to creating groundbreaking solutions in the pharmaceutical industry.

Collaborations: Throughout his career, Troxler has worked alongside esteemed colleagues such as Yves Auberson and Anne-Marie Edwards. These collaborations have undoubtedly contributed to the success and impact of his inventions.

Conclusion: Thomas Josef Troxler represents a remarkable figure in the world of innovation, with a strong focus on pharmaceutical advancements. His extensive patent work and collaborations highlight his vital role in the ongoing pursuit of medical breakthroughs.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…